News & Events

Read QuantuMDx’s latest news to stay up to date with the company, its products, solutions and services.

News

Martin Walton appointed as Chief Financial Officer

NEWCASTLE UPON TYNE, UK, 24 FEBRUARY 2022. QuantuMDx Group Limited (“QuantuMDx”), is pleased to announce the appointment of Martin Walton as Chief Financial Officer. Martin has over 35 years’ experience working within large global companies with the last 15…

News

Q-POC™ SARS-CoV-2 assay receives CTDA legislation approval

NEWCASTLE UPON TYNE, UK, 22 FEBRUARY 2022. QuantuMDx Group Limited (“QuantuMDx”), today announces that its…

News

QuantuMDx confirm its tests detect all known COVID-19 variants

NEWCASTLE UPON TYNE, UK, 26 NOVEMBER 2021. QuantuMDx Group Limited (“QuantuMDx”), today confirms that both…

News

Man wearing a lab coat and testing some samples on a Q-POC machine

QuantuMDx investment from Vita Spring and future cooperation plans

Funds will be used to develop further multiplexing capabilities and menu expansion in collaboration with Sansure, on the Q-POC™ platform Cooperation Agreement to accelerate regional commercialisation of Q-POC™ and its cassettes in China and other South-East Asian markets as well…

Previous Next

CAPTURE-XT explained

Sample cleanup and pathogen concentration

Future development

A novel microfluidic lab-on-a-chip sample clean up and cell concentration technology. Available as a prototype.

Close up of tubercolosis under microscope

Tuberculosis - the challenge

RISK6 explained

Simplified Workflow

Future development

A multiplex PCR laboratory assay to detect host-response-mediated mRNA transcripts present in whole blood. For Research Use Only.

A supercharged platform, with a fast workflow

A smooth user experience with an intuitive interface

A ready to use solution, with all its simplicity, accuracy and speed

A ton of tech behind every result, with intelligent multilingual software algorithms.

A huge leap in rapid multiplex PCR testing, with a small, portable, battery-operated system

A rapid multiplex PCR testing system that delivers results in approximately thirty minutes at the Point of Care.

High quality multiplex PCR testing, as simple as a lateral flow test

A sustainable respiratory infection control solution with the quality of lab-based PCR testing

Results you can trust, with a simple procedure and reliable testing

Meet the challenges of the Winter Season with a respiratory infection test designed to deliver rapid PCR results on demand, in 35 minutes, at the Point of Care.

News & Events

Martin Walton appointed as Chief Financial Officer

Q-POC™ SARS-CoV-2 assay receives CTDA legislation approval

QuantuMDx confirm its tests detect all known COVID-19 variants

QuantuMDx investment from Vita Spring and future cooperation plans

CAPTURE-XT

TB Host Immune Response Assay (TB-HIRA)

Q-POC Platform

Respiratory Solution